Junwei Liu

Junwei Liu

Auto-generated profile, based on publicly available information

Junwei Liu

Guangzhou National Laboratory, Guangzhou, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2025 in Genomics, Proteomics & Bioinformatics
Verified
Journal Article
Open access
JLJunwei Liu
Junwei Liu
XCXiaoping Cen
Xiaoping Cen
CYChenxin Yi
Chenxin Yi
FWFeng-Ao Wang
Feng-Ao Wang
JDJunxiang Ding
Junxiang Ding
YLYixue Li
Yixue Li
The rapid development of biological and medical examination methods has vastly expanded personal biomedical information, including molecular, cellular, image, and electronic health record datasets. Integrating this wealth of information enables precise disease diagnosis, biomarker identification, and treatment design in clinical settings. Artificial intelligence (AI) techniques, particularly deep learning models, have been extensively employed in biomedical applications, demonstrating increased precision, efficiency, and generalization. The success of the large language and vision models further significantly extends their biomedical applications. However, challenges remain in learning these multimodal biomedical datasets, such as data privacy, fusion, and model interpretation. In this review, we provide a comprehensive overview of various biomedical data modalities, multimodal representation learning methods, and the applications of AI in biomedical data integrative analysis. Additionally, we discuss the challenges in applying these deep learning methods and how to better integrate them into biomedical scenarios. We then propose future directions for adapting deep learning methods with model pretraining and knowledge integration to advance biomedical research and benefit their clinical applications.

6 June 2024 in Genome Biology
Verified
Journal Article
Open access
PDF file
FWFeng-Ao Wang
Feng-Ao Wang
ZZZhenfeng Zhuang
Zhenfeng Zhuang
FGFeng Gao
Feng Gao
RHRuikun He
Ruikun He
SZShaoting Zhang
Shaoting Zhang
YLYixue Li
Yixue Li
Cancer is a complex disease composing systemic alterations in multiple scales. In this study, we develop the Tumor Multi-Omics pre-trained Network (TMO-Net) that integrates multi-omics pan-cancer datasets for model pre-training, facilitating cross-omics interactions and enabling joint representation learning and incomplete omics inference. This model enhances multi-omics sample representation and empowers various downstream oncology tasks with incomplete multi-omics datasets. By employing interpretable learning, we characterize the contributions of distinct omics features to clinical outcomes. The TMO-Net model serves as a versatile framework for cross-modal multi-omics learning in oncology, paving the way for tumor omics-specific foundation models.

7 March 2025 in Advanced Science
Verified
Journal Article
Open access
FGFeng Gao
Feng Gao
JDJunxiang Ding
Junxiang Ding
BGBao-Wen Gai
Bao-Wen Gai
DCDu Cai
Du Cai
CHChuling Hu
Chuling Hu
XWXiaojian Wu
Xiaojian Wu
Understanding the prognosis of cancer patients is crucial for enabling precise diagnosis and treatment by clinical practitioners. Multimodal fusion models based on artificial intelligence (AI) offer a comprehensive depiction of the tumor heterogeneity landscape, facilitating more accurate predictions of cancer patient prognosis. However, in the real‐world, the lack of complete multimodal data from patients often hinders the practical clinical utility of such models. To address this limitation, an interpretable bridged multimodal fusion model is developed that combines histopathology, genomics, and transcriptomics. This model assists clinical practitioners in achieving more precise prognosis predictions, particularly when patients lack corresponding molecular features. The predictive capabilities of the model are validated across 12 cancer types, achieving optimal performance in both complete and missing modalities. The work highlights the promise of developing a clinically applicable medical multimodal fusion model. This not only aids in reducing the healthcare burden on cancer patients but also provides improved assistance for clinical practitioners in precise diagnosis and treatment.

1 January 2026 in Fundamental Research
Verified
Journal Article
Open access
SCShiwei Cao
Shiwei Cao
JLJunwei Liu
Junwei Liu
YLYixue Li
Yixue Li
Immune checkpoint blockade (ICB) therapies have revolutionized cancer treatment, showing success across various cancer types. However, there is variability in response rates among different cancers and individual patients. This highlights the critical need for precise patient stratification. Machine Learning and Deep Learning models are increasingly utilized to predict ICB responses by integrating multi-omics data, such as clinical, genomic, radiomic, and transcriptomic information. This review outlines the key methodologies of these predictive models. It underscores their role in enhancing response prediction. We delve into the advanced mechanisms of ICB response and discuss the biological foundations that inform these models. This demonstrates how basic research informs clinical application. We aim to offer comprehensive insights into how artificial intelligence can optimize patient stratification for ICB therapy.

15 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
FWFeng-Ao Wang
Feng-Ao Wang
CYChenxin Yi
Chenxin Yi
JCJiajun Chen
Jiajun Chen
RHRuikun He
Ruikun He
JLJunwei Liu
Junwei Liu
YLYixue Li
Yixue Li
The interplay between transcription factors (TFs) and regulatory elements (REs) drives gene transcription, forming gene regulatory networks (GRNs). Advances in single-cell technologies now enable simultaneous measurement of RNA expression and chromatin accessibility, offering unprecedented opportunities for GRN inference at single-cell resolution. However, heterogeneity across omics layers complicates regulatory feature extraction. We present scTFBridge, a multi-omics deep generative model for GRN inference. scTFBridge disentangles latent spaces into shared and specific components across omics layers. By integrating TF-motif binding knowledge, scTFBridge aligns shared embeddings with specific TF regulatory activities, enhancing biological interpretability. Using explainability methods, scTFBridge computes regulatory scores for REs and TFs, enabling robust GRN inference. Our results further demonstrate that scTFBridge can identify cell-type-specific susceptibility genes and distinct regulatory programs, providing insights into gene regulation mechanisms at the single-cell level.

20 November 2025 in Genome Biology
Verified
Journal Article
Open access
PDF file
CYChenxin Yi
Chenxin Yi
JCJinyu Cheng
Jinyu Cheng
JCJiajun Chen
Jiajun Chen
Wanquan LiuWanquan Liu
Wanquan Liu
JLJunwei Liu
Junwei Liu
YLYixue Li
Yixue Li
Advancements in single-cell RNA sequencing have enabled the analysis of millions of cells, but integrating such data across samples and methods while mitigating batch effects remains challenging. Deep learning approaches address this by learning biologically conserved gene expression representations, yet systematic benchmarking of loss functions and integration performance is lacking. We evaluate 16 integration methods using a unified variational autoencoder framework, incorporating batch and cell-type information. Results reveal limitations in the single-cell integration benchmarking index (scIB) for preserving intra-cell-type information. To address this, we introduce a correlation-based loss function and enhance benchmarking metrics to better capture biological conservation. Using cell annotations from lung and breast atlases, our approach improves biological signal preservation. We propose a refined integration framework, scIB-E, and metrics that provide deeper insights into the integration process and offer guidance for advanced developments in integrating increasingly complex single-cell data. This benchmark highlights the potential of deep learning-based approaches for single-cell data integration, emphasizing the importance of biologically informed metrics and improved benchmarking strategies.